🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Over $15M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Published 17/10/2023, 12:05
© Reuters.  Over $15M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
SRRK
-
ASAN
-

Benzinga - by Lisa Levin, Benzinga Editor.

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Howard Hughes

  • The Trade: Howard Hughes Holdings Inc. (NYSE: HHH) Director William Ackman acquired a total of 116,536 shares an average price of $68.33. To acquire these shares, it cost around $7.96 million.
  • What’s Happening: Howard Hughes said it intends to spinoff new division, Seaport Entertainment, to shareholders by year-end 2024.
  • What Howard Hughes Does: Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA.
Scholar Rock Holding
  • The Trade: Scholar Rock Holding Corporation (NASDAQ: SRRK) 10% owner Invus Public Equities Advisors LLC acquired a total of 2,199,931 shares at an average price of $6.86. To acquire these shares, it cost around $15.09 million.
  • What’s Happening: Scholar Rock priced its upsized $85 million public offering of 12,408,760 common shares at $6.85 per share.
  • What Scholar Rock Does: Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.
Don’t forget to check out our premarket coverage here

Asana

  • The Trade: Asana, Inc. (NYSE: ASAN) President, CEO and Chair Dustin Moskovitz bought a total of 347,802 shares at an average price of $17.96. To acquire these shares, it cost around $6.24 million.
  • What’s Happening: UBS recently initiated coverage on Asana with a Neutral rating and announced a price target of $20.
  • What Asana Does: Asana Inc is a software company. The company provides a platform for work management that helps teams orchestrate work, from daily tasks to cross-functional strategic initiatives.

Check This Out: Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.